Harnessing artificial intelligence and machine learning to accelerate structure-based drug discovery for tuberculosis
Zoozeal Thakur, Lalit Bansal, Promod K. Mehta · Future Medicinal Chemistry · 2025
1. The structure-based drug design (SBDD) leverages the structural insights for rational development of small molecules with optimized affinity/selectivity [1,2]. For Mycobacterium tuberculosis (Mt...